Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Heavy menstrual bleeding in women on oral anticoagulants

Thrombosis Research(2020)10.1016/j.thromres.2020.11.014Source: DataRank Database

Heavy menstrual bleeding in women on oral anticoagulants is a research paper published in Thrombosis Research (2020). On theSindex it has a DataRank of 0. It has been cited 34 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access34 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)OA: greenTopics (26)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Vivia Chi,Paul Sochacki,Owen J. T. McCarty ORCID,Maureen K. Baldwin ORCID,Alison Edelman ORCID

Live enrichment

PubMed:33212377 PMC:PMC7775335

NHLBI NIH HHS

Grant: L30 HL154449

NCATS NIH HHS

Grant: UL1 TR002369

NICHD NIH HHS

Grant: K12 HD085809

NICHD NIH HHS

Grant: R01 HD089957

NHLBI NIH HHS

Grant: R01 HL101972

National Institutes of Health

Grant: 1R01HL101972-01A1

Characterization of coagulation factor-platelet interactions: role of FXI

National Institutes of Health

Grant: 3UL1TR002369-04S2

Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)

National Institutes of Health

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7775335

publisherhttps://api.elsevier.com/content/article/PII:S0049384820306198?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0049384820306198?httpAccept=text/plain

https://doi.org/10.1016/j.thromres.2020.11.014

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775335

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansMenorrhagiaAtrial FibrillationPyridonesAnticoagulantsAdministration, OralRetrospective StudiesFemaleRivaroxabanDabigatran

Keywords

AnticoagulationWarfarinRivaroxabanApixabanHeavy Menstrual BleedingPyridonesAtrial FibrillationAdministration, OralAnticoagulantsHumansFemaleMenorrhagiaDabigatranRetrospective Studies

Sustainable Development Goals

SDG 3: 3. Good health